Search
Close this search box.

Day: December 4, 2023

Zenas BioPharma Strengthens Executive Leadership with Appointment of Jennifer Fox as Chief Business Officer and Chief Financial Officer and Tanya Fischer, M.D., PhD. as Head of R&D and Chief Medical Officer

Expanded strategic and operational leadership positions Zenas for growth as obexelimab advances in late-stage clinical trials for multiple potential I&I indications WALTHAM, Mass., Dec. 04, 2023 (GLOBE NEWSWIRE) —  Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of inflammation and immunology (I&I) directed therapies, today announced the […]

Read More »

Zenas BioPharma Fortalece a Liderança Executiva com a Nomeação de Jennifer Fox como Diretora de Negócios e Financeira, e de Tanya Fischer, MD, Ph.D. como Dirigente de P&D e Médica

Com a expansão dessa liderança estratégica e operacional, a Zenas se posiciona para o crescimento esperado com o avanço do voltadas para inflamações e imunologia nos ensaios clínicos em estágio avançado de várias indicações potenciais de I&I WALTHAM, Mass., Dec. 04, 2023 (GLOBE NEWSWIRE) — A Zenas BioPharma, uma empresa biofarmacêutica global comprometida em se […]

Read More »

Zenas BioPharma renforce sa direction avec la nomination de Jennifer Fox en tant que Chief Business Officer et Chief Financial Officer et de Tanya Fischer, M.D., PhD., en tant que Head of R&D et Chief Medical Officer

Le renforcement du leadership stratégique et opérationnel permet à Zenas de se développer et les essais cliniques en phase avancée sur l’obéxélimab progressent, pour de multiples indications potentielles dans l’I&I WALTHAM, Massachusetts, 04 déc. 2023 (GLOBE NEWSWIRE) — Zenas BioPharma, un laboratoire biopharmaceutique d’envergure mondiale déterminé à devenir un leader dans le développement et la commercialisation […]

Read More »

‫هيئة كهربة الريف (REA) تنشر أكثر من 100 شبكة صغيرة للتنمية الشاملة في نيجيريا على مدار ثلاث سنوات

أبوجا، نيجيريا – EQS Newswire – 4 ديسمبر 2023 – تحت قيادة وزارة الطاقة الفيدرالية في نيجيريا، من المقرر أن تلعب هيئة كهربة الريف (https://REA.gov.ng/) في نيجيريا دورًا رئيسيًا في المؤتمر الثامن والعشرين للأطراف (مؤتمر الأمم المتحدة المعني بتغيّر المناخ لسنة 2023 “كوب 28”) بموجب اتفاقية الأمم المتحدة الإطارية بشأن تغير المناخ، المنعقد في دبي، […]

Read More »

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Paycom Software, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – PAYC

NEW YORK, Dec. 03, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Paycom Software, Inc. (NYSE: PAYC) between May 3, 2023 and November 1, 2023, both dates inclusive (the “Class Period”), of the important January 9, 2024 lead plaintiff deadline in the securities […]

Read More »

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages SunPower Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – SPWR

NEW YORK, Dec. 03, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of SunPower Corporation (NASDAQ: SPWR) between March 9, 2023 and October 24, 2023, both dates inclusive (the “Class Period”), of the important December 26, 2023 lead plaintiff deadline. SO WHAT: If you purchased […]

Read More »

ROSEN, LEADING INVESTOR COUNSEL, Encourages The Beauty Health Company Investors to Secure Counsel Before Important Deadline in Securities Class Action – SKIN

NEW YORK, Dec. 03, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of The Beauty Health Company (NASDAQ: SKIN) between May 10, 2022 and November 13, 2023, both dates inclusive (the “Class Period”), of the important January 16, 2024 lead plaintiff deadline. SO WHAT: If […]

Read More »

ROSEN, A RESPECTED AND LEADING FIRM, Encourages Roblox Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – RBLX

NEW YORK, Dec. 03, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Class A common stock of Roblox Corporation (NYSE: RBLX) between March 10, 2021 and February 15, 2022, both dates inclusive (the “Class Period”). A […]

Read More »

ROSEN, A LEADING AND RANKED FIRM, Encourages Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MDRX

NEW YORK, Dec. 03, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX) between February 26, 2021 and June 13, 2023, both dates inclusive (the […]

Read More »